Literature DB >> 7069166

Toe transfers for congenital hand defects.

A Gilbert.   

Abstract

From 1977 to 1980, 21 second toes were transferred with microvascular anastomoses for congenital hand defects in 17 patients. There have been no vascular failures. Four thumbs were reconstructed with very good functional and cosmetic results. Active motion of the transplanted toe is limited, and the functional results depend on the mobility and musculature of the metacarpal remnant. Growth has been continuous and at least equal to the other toe. Cosmetic results have been very good. It is essential to distinguish between patients showing aplasia and those presenting amniotic band "amputation" syndrome. In the latter case, all structures are close to normal and the results are therefore better. Operative indications must be carefully appraised. If surgical intervention is decided upon, the ideal age is about 18 months, at which time the best integration of the toe is observed.

Entities:  

Mesh:

Year:  1982        PMID: 7069166     DOI: 10.1016/s0363-5023(82)80074-9

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  4 in total

1.  Indications for microsurgical reconstruction of congenital hand anomalies by toe-to-hand transfers.

Authors:  Neil F Jones; Jesse Kaplan
Journal:  Hand (N Y)       Date:  2013-12

2.  A systematic review of outcomes of toe-to-thumb transfers for isolated traumatic thumb amputation.

Authors:  Pao-Yuan Lin; Sandeep Jacob Sebastin; Shimpei Ono; Lillian T Bellfi; Kate Wan-Chu Chang; Kevin C Chung
Journal:  Hand (N Y)       Date:  2011-05-26

3.  Symbrachydactyly.

Authors:  Govindasamy Balakrishnan; S Vijayaragavan; Balakrishnan Somesh
Journal:  Indian J Plast Surg       Date:  2021-11-01

4.  Methods for Congenital Thumb Hypoplasia Reconstruction. A Review of the Outcomes for Ten Years of Surgical Treatment.

Authors:  Dzintars Ozols; Marisa Maija Butnere; Aigars Petersons
Journal:  Medicina (Kaunas)       Date:  2019-09-20       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.